Eilam Yeini
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.
Journal: Science advances
Published: December 13, 2024
Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 21, 2024
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.
Journal: Brain : a journal of neurology
Published: March 30, 2024
interFLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptors.
Journal: NPJ systems biology and applications
Published: October 17, 2023
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 09, 2023
Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
Journal: International journal of cancer
Published: September 27, 2022
3D bioprinted cancer models: from basic biology to drug development.
Journal: Nature reviews. Cancer
Published: September 12, 2022
Sulfonated Amphiphilic Poly(α)glutamate Amine-A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors.
Journal: Pharmaceutics
Published: November 28, 2021
The role of P-selectin in cancer-associated thrombosis and beyond.
Journal: Thrombosis research
Published: October 14, 2021
Last Updated: 09/26/2026